Clinical Trial Update: NIH Substudy of AIN457 (Anti-IL-17 Monoclonal Antibody) for Treatment of Moderate to Severe Crohn's Disease [NA]

View source ↗

Summary

The NIH substudy of the anti-IL-17 monoclonal antibody AIN457 for moderate-to-severe Crohn's disease was terminated, and its results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colitis
• Crohn Disease
• Inflammatory Bowel Disease

Drugs mentioned

• AIN457

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Colitis, Crohn's Disease | NA | Status: TERMINATED | Results posted: 2016-01-11